Immune response to uncoupled peptides of foot-and-mouth disease virus

Immunology
|May 1, 1987
PubMed

Insights

A synthetic peptide from foot-and-mouth disease virus (FMDV) protein VP1 induced virus-neutralizing antibodies in guinea pigs. Specific amino acid sequences and a cysteine residue were critical for this immune response, paving the way for synthetic peptide vaccines.

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Foot-and-mouth disease virus (FMDV) poses a significant threat to livestock.
  • Developing effective vaccines against FMDV is crucial for global animal health.
  • Synthetic peptides offer a promising avenue for vaccine design due to their specificity and safety.

Purpose of the Study:

  • To investigate the immunogenicity of a synthetic peptide representing a specific region of FMDV protein VP1.
  • To identify critical amino acid residues within the peptide responsible for inducing virus-neutralizing antibodies.
  • To explore the potential of this synthetic peptide as a component of a future FMDV vaccine.

Main Methods:

  • Synthesis of uncoupled peptides representing amino acids 141-160 of FMDV VP1.
  • Immunization of guinea pigs with synthetic peptides, with and without incomplete Freund's adjuvant (IFA).
  • Assessment of virus-neutralizing antibody responses and in vitro T-cell proliferation assays.

Main Results:

  • The synthetic peptide induced a virus-neutralizing antibody response in guinea pigs.
  • The response required IFA for primary inoculation and an unblocked cysteine residue at the carboxy-terminus.
  • Amino acids 146-156 were identified as critical for antibody induction, with extension to 137-160 enhancing the response.
  • In vitro studies suggested the carboxy-terminal residues form a T-cell epitope.

Conclusions:

  • A synthetic peptide encompassing residues 141-160 of FMDV VP1 can elicit a virus-neutralizing antibody response.
  • The immunogenicity is dependent on specific peptide sequences and the presence of a free sulfhydryl group.
  • These findings support the development of synthetic peptide vaccines against FMDV.